Dr Amel Havkic on Clinical Adoption in MedTech | MedTech World Middle East Dubai 2026

Why It Matters

Because clinical adoption directly drives revenue and patient outcomes, startups that prioritize bedside integration are more likely to achieve sustainable growth and attract meaningful investment.

Key Takeaways

• Middle East prioritizes differently, showing less willingness to innovate.
• Regulatory approval is ticket, not guarantee of clinical adoption.
• Clinical adoption, not fundraising, should be primary success metric.
• Aligning product launch with clinicians ensures sustainable MedTech business.
• Startups must shift focus from hype to bedside impact.

Summary

At MedTech World Middle East 2026, Dr. Amel Havkic warned that clinical adoption, not just regulatory clearance, is the true litmus test for MedTech startups seeking sustainable growth.

He highlighted that the Middle East market sets priorities distinct from Europe, showing less appetite for rapid innovation. While regulatory approval opens the door, it does not guarantee bedside use; alignment with clinicians and health‑system workflows is essential. Start‑ups often mistake the approval stamp for a finish line, ignoring the complex adoption journey.

Havkic emphasized, “Clinical adoption is the metric in healthcare, not valuations or fundraising rounds,” and described healthcare as a B2B‑to‑C model where doctors are the conduit to patients. He noted that many booths were full, yet true impact only materializes when products become part of daily clinical practice.

The message for founders and investors is clear: shift focus from hype and capital raises to measurable bedside adoption. Companies that embed clinicians early can avoid post‑launch decline and build lasting revenue streams, reshaping how MedTech success is evaluated.

Original Description

During MedTech World Middle East | Dubai 2026, Dr. Amel Havkic, Founder and CEO of EvoMed Consulting, shares why clinical adoption is the real measure of success in MedTech.

He explains that regulatory approval is only the starting point; true impact happens when technologies are adopted by clinicians and used to improve patient care.

Dr. Havkic also highlights the value of MedTech World in bringing together innovators, investors, and healthcare leaders to turn ideas into real-world solutions.

Subscribe for more insights from MedTech leaders.

#MedTechWorld #MTWMiddleEast2026 #EvoMedConsulting #ClinicalAdoption #MedTech #HealthTech